White label – Pompe disease - ClinicalTrials.eu

Study of LY3473329 for Adults with High Lipoprotein(a) Levels at Risk for Heart Problems

Not recruiting

2 1
Investigated Diseases:
- Lipoprotein metabolism disorder
Investigated Drugs:
- Ly3473329
Study of Pembrolizumab for Patients with Advanced Solid Tumors

Not recruiting

2 1 1 1
Investigated Drugs:
- Pembrolizumab
+3
Study on Brexucabtagene Autoleucel for Adults with Relapsed or Refractory Burkitt Lymphoma

Not recruiting

2 1 1 1
Investigated Diseases:
- Burkitt’s lymphoma
Investigated Drugs:
+1
Study of DKN-01 with Drug Combination for Patients with Advanced Colorectal Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Colorectal cancer
- Colorectal cancer metastatic
Investigated Drugs:
Study on Brexucabtagene Autoleucel for Adults with Relapsed/Refractory Richter Transformation (RT)

Not recruiting

2 1 1 1
Investigated Diseases:
- Richter’s syndrome
Investigated Drugs:
+1
Study on MK-7684A and Docetaxel for Treating Metastatic Non-Small Cell Lung Cancer in Patients After Platinum Chemotherapy and Immunotherapy

Not recruiting

2 1 1
Investigated Diseases:
- Non-small cell lung cancer metastatic
Investigated Drugs:
+3
Study on Brexucabtagene Autoleucel for Adults with Relapsed/Refractory Hairy Cell Leukemia

Not recruiting

2 1 1 1
Investigated Diseases:
- Hairy cell leukaemia
Investigated Drugs:
+1
Study on Atezolizumab, Bevacizumab, and Paclitaxel for Advanced Lung Cancer Patients After Immunotherapy and Chemotherapy

Not recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
Study on Aspirin for Preventing Recurrence and Improving Survival in Patients with Stage II and III Colon Cancer

Not recruiting

3 1 1 1
Investigated Diseases:
- Colon cancer stage II
- Colon cancer stage III
Investigated Drugs:
- Placebo
- Acetylsalicylic Acid
Study on Brexucabtagene Autoleucel for Adults with Relapsed/Refractory Waldenstrom Macroglobulinemia Using a Drug Combination

Not recruiting

2 1 1 1
Investigated Diseases:
- Waldenstrom’s macroglobulinaemia
- Waldenstrom’s macroglobulinaemia refractory
Investigated Drugs:
+1

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies